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CocultureNotch4 is a divergent member of the Notch family of receptors that is primarily expressed in the vasculature. Its
expression implies an important role for Notch4 in the vasculature; however, mice homozygous for the Notch4d1
knockout allele are viable. Since little is known about the role of Notch4 in the vasculature and how it functions,
we further investigated Notch4 in mice and in cultured cells. We found that the Notch4d1 allele is not null as it
expresses a truncated transcript encoding most of the NOTCH4 extracellular domain. In cultured cells, NOTCH4
did not signal in response to ligand. Moreover, NOTCH4 inhibited signalling from the NOTCH1 receptor. This is
the ﬁrst report of cis-inhibition of signalling by another Notch receptor. The NOTCH4 extracellular domain also
inhibits NOTCH1 signalling when expressed in cis, raising the possibility that reported Notch4 phenotypes may
not be due to loss of NOTCH4 function. To better address the role of NOTCH4 in vivo, we generated a Notch4
null mouse in which the entire coding region was deleted. Notch4 null mice exhibited slightly delayed vessel
growth in the retina, consistent with our novel ﬁnding that NOTCH4 protein is expressed in the newly formed
vasculature. These ﬁndings indicate a role of NOTCH4 in ﬁne-tuning the forming vascular plexus.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Angiogenesis, the formation of new blood vessels from existing vas-
culature, is critical to the creation of an efﬁcient vascular system. While
angiogenesis does not take place in most adult tissues, it is an essential
aspect of the wound healing response and recovery following ischemia
to reoxygenate and supply nutrients to affected sites. Angiogenesis also
contributes to pathologies such as tumour growth and metastasis, ocu-
lar and autoimmune diseases [1]. Moreover, a lack of appropriate angio-
genesis can cause heart and brain ischemia, neurodegeneration, and
preeclampsia [2]. Thus, proper control of angiogenesis in the embryo
and adult is essential to generate a functioning vasculature and also to
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woodie).A number of signalling pathways including the Notch pathway
are essential for angiogenesis. Notch signalling is necessary for laying
down the primary vascular plexus and subsequently for arterial speciﬁ-
cation [3], vessel size and maturation [4,5] and for arteriogenesis in re-
sponse to ischemia [6–9]. The roles of Notch receptors and ligands in
angiogenesis have been elucidated in embryogenesis. The absence of
the Notch1 receptor or ligands Jagged1 (Jag1), Delta-like 1 (Dll1) or
Delta-like 4 (Dll4) causes embryonic death from disrupted angiogenesis
[3,10–12]. The NOTCH1 receptor is the most important Notch receptor
in terms of its role in the vasculature. Notch1 is widely expressed in
the embryo generally as well as in the vasculature [13] and in its ab-
sence embryos die at embryonic day (E) 9.5with reduced and abnormal
angiogenesis of the embryo, yolk sac and placenta [11,14]. The most
potent ligand of Notch with respect to angiogenesis is DLL4. Loss of
even one copy of Dll4 results in embryonic lethality with extensive
angiogenic defects including pericardial edema, aortic atresia, and
loss of the internal carotid artery and yolk sac vessels [10,15].
Notch signalling is important for both sprouting and intussusceptive
(or splitting) angiogenesis [16–19]. During sprouting angiogenesis,
tip cells arise at the leading edge of the expanding vascular plexus.
These tip cells prevent neighbouring vascular endothelial cells from
adopting the same fate through the Notch-dependent processes of
lateral induction and lateral inhibition [20]. Tip cells at the leading
edge of the vascular plexus express Dll4 in response to VEGF and DLL1
in the surrounding tissue [21,22]. DLL4 in tip cells is likely to induce
Notch signal transduction in adjacent cells and thereby suppresses the
tip cell phenotype in these adjacent stalk cells [17]. Notch signalling,
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the extent of vessel branching. Accordingly, reduced levels of DLL4-
Notch signalling disrupt sprouting angiogenesis due to overproduction
of tip cells [17–19].
The Notch signal transduction pathway is critical formany aspects of
embryonic development and homeostasis in the adult. Canonical Notch
signalling occurs in a juxtacrine manner as Notch receptors and Delta,
Serrate, Lag-2 (DSL) family ligands are transmembrane proteins. Signal-
ling relies on post-translational modiﬁcation of Notch, its presentation
on the cell surface and receptor cleavage; these processes have largely
been identiﬁed through the study of Drosophila Notch and mammalian
NOTCH1 andNOTCH2.MammalianNotch receptors are synthesised as a
single polypeptide and undergo S1-cleavage in the trans-Golgi network
(TGN) by Furin or a Furin-like convertase [23,24]. A heterodimer is
formed by noncovalent linkage of the extracellular domain with the
transmembrane and intracellular domains. Heterodimeric Notch is
then transported to the cell surface where it can interact with ligands
of the DSL family aswell with other families of ligands, on neighbouring
cells (trans interaction) [23,24]. In the case of NOTCH1, surface presen-
tation of heterodimer is required for potent signal transduction [25]. In-
teraction between ligand and receptor in trans results in proteolytic
cleavage (S2-cleavage) of Notch by ADAM10 [26–28]. The γ-secretase
complex subsequently cleaves S2-cleaved Notch within the membrane
(S3-cleavage), releasing the Notch intracellular domain (ICD) [29,30].
The ICD translocates to the nucleus and forms a complex with the
DNA-binding protein CSL and MAML proteins. Direct targets of Notch
include members of the hairy/enhancer-of-split (HES) and HES-
related (HEY) family of bHLH transcription factors, Nrarp, and Lfng
[31–34].
Of the four mammalian Notch receptors, signalling via NOTCH1 and
NOTCH2 is best understood and it is assumed that NOTCH3 and
NOTCH4 signal in a similarmanner, as the ICD of each receptor interacts
with CSL and transactivates Notch target genes [32,35,36]. In particular,
Notch4 is the most divergent of the four mammalian Notch receptors
and is distinct as it is expressed almost exclusively in the vasculature,
compared to Notch1, which is expressed in virtually all tissue types in
the developing embryo [37]. In cultured cells, NOTCH4 is reported to
signal in response to ligand [38,39] but little else is known about its
mechanism of signal transduction. Studies inmice show that endotheli-
al speciﬁc expression of constitutively active NOTCH4 (encoded by the
int3 allele) causes dramatic vascular changes including lack of small
branched vessels, loss of vessel integrity [40,41] and arterial shunts
[42,43]. Induction of int3 expression in mature vessel endothelium
(postnatally), causes expression of the Notch target gene EphrinB2 and
increased smooth muscle layers, resulting in arterialisation of venous
vessels [40]. Suchﬁndings, coupledwith the endothelial speciﬁc expres-
sion pattern of NOTCH4, imply that upon activation NOTCH4 would
illicit similar effects on the vasculature and in so doing function to con-
trol the growth and differentiation of endothelial cells in vivo. However,
this does not appear to be the case as mice homozygous for the Notch4
knockout allele (Notch4d1) are viable [11]. Notch4d1 interacts with a
Notch1 null allele as about half of the embryos homozygous for both
Notch4d1 and Notch1 null are more severely affected than Notch1 null
embryos [11]. These defects include open neural tubes, fewer somites
and collapse of the anterior cardinal vein [11]. Adult mice homozygous
for the Notch4d1 allele exhibit slightly elevated blood pressure [9], de-
layed tumour onset and reduced tumour perfusion [44]. Since Notch4
and Notch1 are expressed in the vasculature, it is considered that
Notch1 compensates for the loss of Notch4 [13,37,45–47].
Currently our understanding of the role of Notch4 in the vasculature
is not clear. Therefore we further examined the Notch4d1 allele in mice,
and the signalling potential of the wildtype NOTCH4 receptor in
cultured cells. We report that the Notch4 knockout allele Notch4d1,
expresses a truncated transcript encoding most of the extracellular do-
main of the receptor. Moreover, in cultured cells we ﬁnd that NOTCH4,
unlike the other Notch receptors, lacks detectable signalling capacityand instead inhibits signalling from NOTCH1 when both receptors are
expressed in the same cells. Importantly, the truncated NOTCH4d1
receptor expressed by Notch4d1 mice retains the capacity to inhibit
NOTCH1 signalling in cis; it is therefore not a Notch4 null allele. To
determine the effect of a complete loss of Notch4, we generated
mice lacking the entire Notch4 coding region. These Notch4 null mice
are viable but they exhibit a delayed growth in retinal angiogenesis,
pointing to a subtle role for NOTCH4 in developmental angiogenesis.
2. Materials and methods
2.1. Mice
Notch4tm1Grid, referred to as Notch4d1, was a kind gift from Thomas
Gridley [11]. A mouse line, Notch4tm1(KOMP)Vlcg referred to as Notch4−,
carrying a deletion allele of Notch4 was made by the Australian
Phenomics Network using embryonic stem cells obtained from the
KOMP repository (project number 10800). Gene targeting of the inser-
tion cassette (Zen-Ub-1), containing the neomycin resistance gene
and a LacZ reporter, replaced the entire open reading frame of Notch4
(bases 34,724,940—34,701,394 of chromosome 17). The resulting mice
were housed at the Biocore, Victor Chang Cardiac Research Institute
and kept in a perpetual 12 hour light/dark cycle and fed ad libitum.
Notch4+/− males and females were paired for timed matings in
the afternoon and plugs checked the following morning. Pairings
were left for 3 days before separation or identiﬁcation of a vaginal
plug. Plug date was considered 0.5 days old and pregnant females
were culled for embryo dissection 10 days post-plug. The day of
birth was considered P0 and mice were culled for retina extraction
5 days later. Genotyping of Notch4d1 mice was carried out using
primers described in [11]. Primers used to characterise the Notch4d1
allele were 5′-CGCAGTGTGACTCTGAGGAG-3′ and 5′-TGTCTGTTGT
GCCCAGTCAT-3′ (exon 21 to the Notch4d1 insertion cassette), 5′-
CTGGGCACAACAGACAATCGGC-3′ and 5′-TGTCTGTTGTGCCCAGTC
AT-3′ (Notch4d1 insertion cassette), 5′-ATTGCATCGCATTGTCTGAG-
3′ and 5′-TCCATCCTCATCCACTTCGGCCTC-3′ (Notch4d1 insertion cas-
sette to exon 25), 5′-GCTCTTGCCACTCAATTTCCC-3′ and 5′-GCCACC
ATTCTTGCAGAGTTG-3′ (Notch4 exon 1–3), 5′-GCTGCACTGTGAGG
AGAAGA-3′ and 5′-ATCGAGCAGTGTGTGGACAG-3′ (Notch4 exon 5–
16). Notch4−mice were genotyped using primers NeoFwd (5′-TCATTC
TCAGTATTGTTTTGCC-3′) and SDRev (5′-CTGGAGAACATGGCCTCATC-
3′) and SU (5′-CCTTCCTGGGTCACAGTAGC-3′) and LacZRev (5′-GTCT
GTCCTAGCTTCCTCACTG-3′). Reverse transcription was performed
using Superscript III (Life Technologies) and oligo-dT according to the
manufacturer's instructions. PCR was performed with Taq polymerase
(Roche) according to the manufacturer's instructions.
2.2. DNA constructs
Notch4 expression plasmidsweremade by subcloning a XhoI toNotI
fragment from pYXNotch4 (I.M.A.G.E clone number 6855960) into
pENTR2B (Life Technologies). The 5′ end of Notch4 was ampliﬁed
using primers 5′-GAGGGGGAATTCCTGAAGAGGGAGAGGAGA-3′ and
5′-ATCGAGCAGTGTGTGGACAG-3′ from C57Bl/6J lung cDNA reverse
transcribed using the primer 5′-ATCGAGCAGTGTGTGGACAG-3′ and
MonsterScript reverse transcriptase (Epicentre) according to the
manufacturer's instructions. The ampliﬁed product was subcloned into
the above plasmid using EcoRI and XhoI sites. The 3′ end of Notch4
was ampliﬁed from pYXNotch4 using the primers 5′-CACTTGGTCGGT
GGACTTG-3′ and 5′-CGCAGCCGGCCGGTTCAGATTTCTTACAACCG-3′ to
create an in frame fusion for tagging the C-terminus. pENTR2BNotch4d1
wasmade by cloning aNotch4 fragment, ampliﬁedusing the primers 5′-
GCTGCACTGTGAGGAGAAGA-3′ and 5′-ATAGCTCGAGATGCAGGTTAGA
GGGATTTC-3′, into the XhoI sites of pENTR2BNotch4. pCMXFLAG was
generated by cloning annealed oligos 5′-GATCCGACTACAAAGACGAT
GACGACAAGTAAG-3′ and 5′-CTAGCTTACTTGTCGTCATCGTCTTTGTAG
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reactions (Life Technologies) were used to transfer the Notch4 and
Notch4d1 cDNAs to pCAGiPuroHA and pCMXHA [49] and pCMXFLAG.
To generate NOTCH4-Ruby-pCDNA5 FRT/TOAU, Rubywasﬁrst PCR am-
pliﬁed from pmRuby-c1 [50] using 5′-TATATGGATCCAACAGCCTGATCA
AAGAA-3′ and 5′-TATATGCTAGCTTACCCTCCGCCCAG-3′ and cloned
into the BamHI and NheI sites of pCMX-PL2 and subsequently into the
inducible vector pCDNA5 FRT/TO AU [51]. pENTR2BNotch4 was used
to gateway clone Notch4 into the resulting vector. pBSN4EP was made
by subcloning an EcoRI to PmlI fragment into the EcoRI and SmaI sites
of pBluescript II KS(-) (Agilent). Notch1-myc (a gift from Jeff Nye)
was cloned into the EcoRI site of pCMX, generating pCMXNotch1myc.
A gateway reaction was used to transfer Notch1 from pENTR2BNotch1
into pCMXHA to generate pCMXNotch1HA. pCS2Notch1ΔE-6myc and
pCS2Notch4ΔE-6myc were kind gifts from Raphael Kopan [52].
Notch1ΔEHA was made by subcloning a BglII to XhoI fragment of
pCMXNotch1HA into BglII to XhoI of pCS2Notch1ΔE-6myc. Notch4ΔEHA
was made by subcloning an AﬂII to NheI fragment of pCMXNotch4HA
into the AﬂII and XbaI sites of pCS2Notch4ΔE-6myc. Notch1ΔE-GVP
[53] was modiﬁed by removing the Gal4/VP16 sequences by digesting
with AscI and religating. A NotI fragment was subcloned from this plas-
mid into pBluescript II KS(-) (Agilent) to make pBSNotch1:1. A product
ampliﬁed from pCMXNotch1HA using the primers 5′-CTCGGGCCCACG
TAGTCCCACCTG-3′ and 5′-AGGGAACCAGAGCTGGCCATGGGC-3′ was
digested with BamHI and AscI and cloned into the BamHI and AscI sites
of pBSNotch1:1. A BamHI to HindIII fragment was then subcloned
into pCMXNotch1HA to make the Notch1:1 expression plasmid. A
product ampliﬁed from pCMXNotch4HA using the primers 5′-CTGC
ATCTCCACACCCTGT-3′ and 5′-AGGGCCCCATGGGCGCGCCGCCGT-3′
was digested with XhoI and AscI and subcloned into pBSNotch1:1
to create pBSNotch4:1. A BstEII to NotI fragment was subcloned
into pCMXNotch4HA to make the Notch4:1 expression plasmid. A
product ampliﬁed from pCMXNotch4HA using the primers 5′-ACGG
CGGCGCGCCCATGGGGCCCT-3′ and 5′-TCCATCCTCATCCACTTCGGCC
TC-3′ was cut with AﬂII and AscI and subcloned into the above sites
of pBSNotch4:1. A BstEII to AﬂII fragment was subcloned into
pCMXNotch4HA to make the Notch4:4 expression plasmid. The
Notch1:4 expression plasmid was made by subcloning an EcoRI to AscI
fragment from the Notch1:1 expression plasmid into the Notch4:4
expression plasmid. A 320 bp BamHI fragment from p6×TP1-luc con-
taining six copies of the TP1 sequence [54] was cloned into the BglII
site of pGL4.23 (Promega) forming the Notch luciferase reporter
pGL4-6×TP1-Luc.
2.3. Cell culture, live imaging and luciferase assays
C2C12 and NIH3T3 lines were grown in DMEM containing 2 mM
L-glutamine and 10% FCS in a humidiﬁed incubator at 37 °C and 5%
CO2. Subconﬂuent cultures were passaged by detaching the cells
with TrypLE Express (Gibco/BRL) and diluting 1/10 every 2–3 days.
For transfections cells were seeded at 2.5 × 104 cells per cm2 and
grown overnight at 37 °C in a humidiﬁed chamber containing 5%
CO2. Cells were transfected with Lipofectamine LTX Reagent follow-
ing the manufacturer's instructions (Life Technologies). Mouse aor-
tic endothelial cells (MAEC) were grown in M199 media containing
2 mM L-glutamine, 10 mM HEPES, 0.1 mg/ml Heparin sodium, 5 ng/ml
VEGF and 5% FCS [55] and transfected with Lipofectamine 2000 reagent
following the manufacturer's instructions.
For live-cell imaging experiments, C2C12 cells stably expressing a
NOTCH1-GFP fusion receptor (NOTCH1-GFP cells) were seeded onto
30 mm round coverslips in 10% FCS in DMEM. The following day cul-
tures were cotransfected with a tetracycline-inducible NOTCH4-Ruby
expression construct (NOTCH4-Ruby-pCDNA5 FRT/TO AU) and a Tet
Repressor protein expression plasmid (pCDNA6/TR; Life Technologies).
Media was replaced on the cells 5 h post-transfection and left to incu-
bate overnight. A coverslip was transferred to the POCmini imagingapparatus (Pecon). Cells were rinsed in 1 ml Phenol Red-free DMEMgfp
media (Evrogen) containing 10% FCS and 1 μg/ml doxycycline and left
in a ﬁnal 1 ml for imaging. Cells were mounted in an incubation cham-
ber at 37 °C and 5% CO2 immediately after addition of doxycycline and
left to equilibrate. Images were acquired using a 63× 1.4 NA oil objec-
tive on an AxioObserver Z1 Inverted microscope equipped with 710
confocal scan head (Zeiss). Images were captured over the course of
5 h at 7.5 min intervals, 1–2 h after placement in the chamber.
Notch signal transduction was induced by coculturing ligand pre-
senting cells with cultures of responding cells as described elsewhere
[49,56,57]. NIH3T3 cells expressingmouse DLL4 were generated by sta-
bly transfecting cells with pCAG-mDll4-IRESpuro. Cultures were grown
in 1.5 μg/ml puromycin for 10 days, colonies picked and screened by
immunoﬂuorescence and immunoblotting for DLL4 expression.
Responding cells were seeded at 5 × 104 cells per well into 24-well
tissue culture plates and grown overnight. Cells were transfected
for 6 h with pCMXNotch1HA, pCMXNotch4HA or the vector control,
plus the Notch responsive reporter pGL4-6×TP1-Luc and the Renilla
luciferase transfection control, pCMXren [57]. Transfection mixes
were aspirated and 5 × 104 ligand presenting cells were added to cul-
tures and incubated overnight. Cocultures were lysed in 100 μl of
passive lysis buffer and the luciferase activity was measured using
the Dual Luciferase Kit according to the manufacturer's instructions
(Promega). Fireﬂy luciferase activity was normalised to the Renilla
luciferase activity generated from pCMXren.
2.4. C2C12 cell differentiation
C2C12 cells stably expressing NOTCH4HA and NOTCH4d1HA were
created by transfecting cells with pCAG-Notch4HA-IRESpuro and
pCAG-Notch4d1HA-IRESpuro, respectively. Cultures were grown in
1.5 μg/ml puromycin for 10 days, colonies picked and screened by im-
munoﬂuorescence and immunoblotting for uniform NOTCH4 expres-
sion. Control lines were also generated by stable transfection of pCAG-
IRESpuro. Three clones of each Notch4HA, Notch4d1HA and pCAGiPuro
were seeded on plastic coverslips (Sarstedt) at 50% conﬂuence per
well of a 6-well dish. After 24 h fresh media was added and cells
were grown to conﬂuence over 6 days in 10% FCS DMEM. At days 0,
2, 4 and 6 cells were ﬁxed and stained with MF20 (1/20; DSHB) and
TO-PRO 3 (1/1000; Life Technologies).
2.5. Co-immunoprecipitation and western blotting
Co-immunoprecipitations were performed with an anti-FLAG an-
tibody (1/150 clone M2; Sigma) or an equal amount of non-speciﬁc
mouse IgG (Jackson) as described in [58] except that Protein G
Dynabeads (Life Technologies) were used. Western blots were car-
ried out with the following antibodies: anti-HA (1/1000, clone
16B12; Covance), anti-myc (1/250, clone 9E10; DSHB), and anti-β-
Actin (1/5000, clone AC-15; Sigma).
2.6. RACE
The 3′RACE protocol was adapted from [59,60]. One microgram of
RNA isolated using the Purelink micro-midi RNA extraction kit (Life
Technologies) from neonatal (P5) mouse lung was heat denatured at
65 °C for 5 min in the presence of 50 pmol of 3′RACE primer 5′-CCAG
TGAGCAGAGTGACGAGGACTCGAGCTCAAGCTTTTTTTTTTTTTTTTTVN-3′
and reverse transcribed with SuperScript III (Life Technologies) accord-
ing to the manufacturer's instructions followed by heat inactivation
(70 °C for 20 min) and RNaseH (Life Technologies) treatment for
20min at 37 °C. The cDNAwas puriﬁedwith the QIAquick PCR Puriﬁca-
tion Kit (Qiagen)with an additional 35% guanidine hydrochloridewash.
The cDNA was PCR ampliﬁed using the primers 5′-CCAGTGAGCAGAGT
GACG-3′ and 5′-TAGCCAACGCCTTCTACTGC-3′ with Platinum Taq (Life
Technologies). The PCR conditions were 94 °C for 5 min followed by
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followed by a ﬁnal incubation at 72 °C for 15 min. The PCR reaction
was puriﬁed with the QIAquick PCR Puriﬁcation Kit (Qiagen) includ-
ing a wash with 35% guanidine hydrochloride. A nested PCR was per-
formed on 5% of the reaction using the primers 5′-GAGGACTCGAGC
TCAAGC-3′ and 5′-AGGAGGAGACTGGGATGGAG-3′ and Platinum
Taq. The PCR conditions were 94 °C for 5 min followed by 35 cycles of
94 °C for 10 s, 60 °C for 10 s and 72 °C for 1 min followed by a ﬁnal in-
cubation at 72 °C for 15min. The resulting PCR product was cloned into
pGEMeasyT (Promega) according to the manufacturer's instructions.
The cloned product was sequenced using the primers T7 5′-TAATAC
GACTCACTATAGGG-3′ and SP6 5′-ATTTAGGTGACACTATAGAA-3′.
2.7. Northern blotting
Northern blotting was performed as described previously [61].
Neonatal mouse lung RNA was prepared using TRI reagent (Sigma)
and separated on a 0.7% denaturing agarose gel before capillary
transfer to a Hybond N+ membrane. An RNA probe was prepared
from pBSN4EP by reverse transcription using T7 polymerase (Ambion)
and EasyTides Uridine 5′-triphosphate α-32P (PerkinElmer) according
to the manufacturer's instructions. Probes were hybridised over-
night in 5 × SSC, 5 × Denhardt's solution, 50% formamide, 1% SDS,
100 μg/ml Torula yeast RNA, and 100 μg/ml herring sperm DNA at
60 °C. The membrane was washed 3 times in 2 × SSC, 0.1% SDS for
15 min at room temperature, 2 times in 0.2 × SSC, 0.1% SDS at 60 °C
for 15 min and 2 times in 0.2 × SSC, 0.1% SDS at 68 °C for 15min before
exposure to X-ray ﬁlm. Bands were quantiﬁed using ImageJ software.
2.8. RNA in situ hybridisation, LacZ staining and wholemount
immunoﬂuorescence
RNA in situ hybridisation was performed as described previously
[62]. The probe against exons 1–5 of Notch4 was made using an EcoRI
linearised pBSN4EP template DNA and T7 RNA Polymerase. LacZ stain-
ing was performed on ﬁxed embryos (10 min in 0.2% glutaraldehyde,
0.1 M phosphate buffer (pH 7.3), 2 mM MgCl2, 5 mM EGTA) washed
twice for 10 min in 0.1 M Na phosphate buffer (pH 7.3), 2 mM MgCl2,
0.1% Na deoxycholate, and 0.02% NP40 and stained in wash buffer con-
taining 0.232mMNaCl, 5 mMK3Fe(CN)6, 5 mMK4Fe(CN)6, 0.24 mg/ml
spermidine, and 1 mg/ml X-gal for 72 h at 37 °C. Stained embryos were
washed and photographed.Wholemount immunoﬂuorescence on neo-
natal mouse retinas was performed as follows. Mouse pups at 5 days
post birth were sacriﬁced by decapitation and tail clips taken for
genotyping. Eyes were enucleated and ﬁxed in 4% PFA at 4 °C for
10 min on ice. An incision was made using dissecting forceps just
below the lens and the pigmented epithelium and outer layers re-
moved. The vitreous and associated hyaloid vasculature were removed
and the dissected retina was ﬁxed for a further 2 h in 4% PFA at 4 °C
followed by three 5 min washes in PBS. Non-speciﬁc binding was
prevented by incubation for 1 h at room temperature in Block (5% don-
key serum, 0.3% Triton X-100 in PBS). Anti-PECAM1 (1/200, clone
MEC13.3; BD Biosciences) and anti-ACTA2 (1/100, clone 1A4, Dako)
were diluted in Block, added to retinas and incubated with gentle agita-
tion overnight at 4 °C. The retinas were washed six times for 15 min in
PBST (PBS containing 0.1% Triton X-100) then incubated with anti-
mouse 488 and anti-Rat Cy3 secondary antibodies (1/500; Jackson) for
2 h at room temperature in the dark. Following six 15 min washes in
PBST at room temperature, four radial cuts were made in the retina to
allow it to be laid ﬂat on a microscope slide. The retinas were then
mounted in ProLong Gold Antifade reagent (Life Technologies). Retinas
were either imaged as z-stacks in a 3 × 3 tile using a 10× 0.45 NA objec-
tive or in a 6 × 6 tile using a 20× 0.8NAobjective on anAxioObserver Z1
microscope ﬁtted with a 710 confocal scan head (Zeiss). NOTCH4 reac-
tivity was detected in retinas using anti-NOTCH4 (1/2000, cloneHMN4-
14; iCyt) and tertiary ampliﬁcation with biotinylated donkey anti-armenian hamster secondary antibody (1/1000; Jackson) followed by
Cy3-conjugated streptavidin (1/1000; GeneTex) in conjunction with
endothelial staining using Alexa-488 Griffonia simplicifolia Isolectin B4
(1/200; Life Technologies).
2.9. Image analysis and statistics
Z-stacks were maximum intensity projected using the Zen 2009
software (Zeiss) and then thresholded and converted to a binary format
in ImageJ (NIH). The perimeter of the vascular bed was deﬁned as a
region-of-interest in ImageJ using the tracing tool. The vascular area
was determined by dividing the area within this perimeter by the
mean area of the heterozygotes within each litter. Litters were excluded
if they contained fewer than twoheterozygotes. RapidAnalysis of Vessel
Elements (RAVE) software was used to quantify changes in the organi-
sation of the vasculature [63]. Maximum intensity projected images
were subjected to a 2 pixel Gaussian Blur in ImageJ then converted to
a binary format. All non-contiguous pixels positive for PECAM1were ex-
cluded from analysis. Size valueswere set to 1 in RAVE. Sigma andmax-
imum radius inputs were set at 5 and 30, respectively. Total vessel
length and fractal dimension were determined by RAVE. Vessel length
density was expressed as the ratio of total vessel length to vascular
area for individual retinas. In order to correct for inter-litter variation,
all measurements are shown relative to the mean of the heterozygotes
in each mouse litter. Litters were excluded from further analysis if
they contained fewer than two heterozygotes.
Measurements were analysed using two-tailed unpaired Student's
T-test with PRISM software (Graphpad) and considered signiﬁcantly
different if P b 0.05.
3. Results
3.1. Notch4d1 mice express a truncated Notch4 transcript
In the course of studying the role of Notch4 during mouse em-
bryogenesis, we examined its expression pattern by RNA in situ
hybridisation using a probe designed against the 5′ end (exons 1–5)
of the Notch4 transcript (Fig. 1A; ex1/5 probe). To demonstrate that
the probe was speciﬁc to Notch4, embryos homozygous for the pub-
lished Notch4 allele (Notch4tm1Grid; hereafter termed Notch4d1) were in-
cluded in our analysis as a negative control [11]. Notch4d1 is the only
reported knockout allele ofNotch4 and lacks exons 22 and 23; itwas de-
signed to prevent transcription of downstream sequences encoding the
NOTCH4 intracellular domain (NOTCH4ICD) [11]. We observed that
Notch4 transcripts were largely restricted to the vasculature as report-
ed, and at E10.5 were most obvious in the intersomitic vessels
(Fig. 1B; [37,46]). In addition to its vascular expression, we observed
Notch4 expression in a caudal site not previously reported. In this region
Notch4 was expressed in the tail bud and in the presomitic mesoderm
(Fig. 1B). Unexpectedly, Notch4 transcripts were also detected in
Notch4d1/d1 embryos suggesting that the Notch4d1 allele produced a
stable transcript in the same pattern as Notch4+/+ embryos
(Fig. 1B). Genomic PCR with primers amplifying within the targeted
region (Fig. 1C; ex22), within the selection cassette (Fig. 1C; neo) as
well as ﬂanking the 5′ and 3′ recombination sites (Fig. 1C; ex21/neo
and neo/ex25) conﬁrmed that the Notch4d1 allele was targeted as re-
ported [11]. To conﬁrm that the Notch4d1 locus produces a transcript,
reverse transcription PCR (RT-PCR) was performed on oligo-dT primed
neonatal lung cDNA of each genotype produced by Notch4+/d1 inter-
cross. Primers amplifying within the targeted region (Fig. 1D; ex22)
conﬁrmed that exon 22wasnot transcribed inNotch4d1/d1mice. Primers
amplifying exons 1 to 3 (Fig. 1D; ex1/3) and exons 15 to 16 (Fig. 1D;
ex15/16) upstream of the targeting cassette produced PCR products in
all three genotypes, indicating that the Notch4d1 allele produced a
spliced and polyadenylated transcript that included at least exons 1 to
16 of the Notch4 gene. To determine the extent of this transcript we
Fig. 1. TheNotch4d1 allele overexpresses a truncatedNotch4 transcript in vivo. (A) Schematic
representation of theNotch4 andNotch4d1 alleles. The position of PCR products and probes is
indicated by lines. (B) Expression of transcripts derived from exons 1–5 (ex1/5 probe) in
Notch4+/+ and Notch4d1/d1 E10.5 embryos shown by wholemount RNA in situ hybridisation.
Scale bar: 1.7mm forwhole embryos (left) and 1mm for tail region (right) (C) Conﬁrmation
of theNotch4 locus structure in theNotch4d1 allele by PCR fromgenomic DNA. The PCR prod-
ucts are 313 bp (ex22); 469 bp (ex21/neo); 518 bp (neo); 735 bp (neo/ex25). (D) Detection
of Notch4d1 transcripts containing sequences 5′ of the neo cassette insertion in neonatal lung
RNA by RT-PCR. The PCR products are 313 bp (ex22); 518 bp (neo); 199 bp (ex1/3); and
160 bp (ex15/16). (E) Detection of transcripts containing Notch4 exons 1–5 in lung from
Notch4+/+, Notch4+/d1 and Notch4d1/d1 neonates by northern blot analysis. White and black
arrows indicate the Notch4 and Notch4d1 transcripts, respectively. Molecular weights (kb)
are shown on the left. (F) Quantitation of transcripts detected by northern blot containing
exons 1–5 in lung fromNotch4+/+,Notch4+/d1 andNotch4d1/d1 neonates. Average expression
and standard error of themean relative to 28S rRNA, n=3 for each genotype. Datawas test-
ed for statistical signiﬁcance as described in the experimental procedures (Section 2.9).
*P b 0.05. Exons (ex). Neomycin (neo).
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Notch4d1/d1 neonatal lung cDNA. A single RACE product was ampliﬁed
and found to be a fusion mRNA between Notch4 and the neomycin
(neo) selection cassette (Fig. S1A). An identical transcript was found
in all mice tested (n= 6). The transcript was polyadenylated 18 nucle-
otides 3′ of the SV40 polyadenylation signal of the neo cassette. Exon 21
of theNotch4 locus was spliced to a cryptic 3′ intron acceptor within the
neo cassette. The Notch4 open reading frame continued into the neo
gene encoding an additional 10 amino acids before encountering a ter-
mination codon. An additional cryptic exon is present in the 3′UTR of
the transcript 51 nucleotides downstream of the termination codon.
Nonsensemediated decay causes the degradation ofmRNAsharbouring
termination codons more than 50–55 nucleotides from an exon–exon
junction [64]. It was therefore possible that we had simply detected a
residual transcript left over following nonsense mediated decay al-
though we did not observe reduced expression in Notch4d1 embryos
by RNA in situ hybridisation (Fig. 1B). To exclude this possibility and
to conﬁrm that the single transcript we isolated by RACE (Fig. S1A)
was unique, we performed northern blot analysis using a probe up-
stream of the targeting site encompassing exons 1 to 5. A single
Notch4 transcript was detected in Notch4+/+ lung (Fig. 1E). A single
faster migrating transcript was detected in Notch4d1/d1 lung and in
Notch4+/d1 both transcripts were detected. Notch4 transcripts were
overexpressed 2.6-fold in Notch4d1/d1 and 1.7-fold in Notch4+/d1 lung
(Fig. 1F). In summary, these data demonstrate that the Notch4d1 allele
overexpresses a truncated Notch4 transcript.
3.2. Notch4d1 mice overexpress a truncated NOTCH4 protein
The truncated transcript expressed by the Notch4d1 allele is pre-
dicted to encode most of the extracellular domain of the receptor in-
cluding all 29 EGF-like repeats and the Lin12-Notch repeats LNR-A
and LNR-B followed by 10 amino acids (Fig. S1A). This putative
NOTCH4d1 protein therefore lacks the third LNR repeat (LNR-C),
heterodimerisation domain (HD), transmembrane domain and the
intracellular domain (Fig. S1B). To determine if the Notch4d1 allele
produced a stable protein, we performed wholemount immunoﬂuo-
rescence to detect NOTCH4 protein in the retinal vasculature; a
known domain of Notch4 mRNA expression [65]. Retinas from
5 day old (P5) Notch4+/+, Notch4+/d1 and Notch4d1/d1 mice were
stained with an antibody that speciﬁcally detects the extracellular
domain (EC) of mouse NOTCH4 (Fig. S2) and ﬂuorescently labelled
G. simplicifolia Isolectin B4 to mark the vasculature. In wildtype retinas,
NOTCH4 reactivity was detected in the developing arteries and veins
(Fig. 2A,B,D), similar to expression of the transcript [65]. However,
NOTCH4 reactivity was also found in capillaries. NOTCH4 expression
was strongest in the newly laid down primary plexus at the periphery
of the developing vasculature, compared with more mature vessels
closer to the optic nerve that had undergone remodelling (Fig. 2C,
Fig. S2B). Tip and stalk cells in the primary plexus both expressed
NOTCH4, as did ﬁlopodial extensions from the tip cells (Fig. 2E).
NOTCH4 reactivity was detected in the developing arteries of
Notch4d1/d1 retinas, demonstrating that a NOTCH4 protein is pro-
duced by the Notch4d1 allele (Fig. 2D). Interestingly, Notch4+/+ ret-
inas exhibited much weaker reactivity and Notch4+/d1 mice showed
intermediate expression. Thus, the Notch4d1 allele overexpressed a
truncated form of NOTCH4.
3.3. NOTCH4 and NOTCH4d1 inhibit signalling via NOTCH1
The Notch4d1 allele expresses a truncated NOTCH4 protein lacking
the intracellular domain and therefore cannot transduce a canonical
Notch signal. It also lacks the transmembrane domain and is therefore
soluble and possibly secreted. Addition of soluble Notch extracellular
domain protein inhibits ligand-dependentNotch signalling [66–68], im-
plying that soluble forms of NOTCH4 such as NOTCH4d1 could inhibit
Fig. 2. The Notch4d1 allele overexpresses a truncated NOTCH4 protein in vivo. (A–C)Wholemount immunoﬂuorescent detection of NOTCH4 (red) in wildtype retinas at P5 in arteries (A),
veins (B) and at the vascular front (C). Vasculaturewas labelledwith Alexa-488 conjugated Isolectin B4 (IB4; green). (D,E)Wholemount immunoﬂuorescent detection ofNOTCH4 (red) in
Notch4+/+, Notch4+/d1 and Notch4d1/d1 P5 retinas. (D) Arterial and (E) tip cell staining for NOTCH4 in IB4-positive endothelial cells (green). Scale bar: 100 μm (A–C) and 20 μm (D, E).
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hibits ligand-induced signal transduction when expressed in cells
coexpressing (that is, in cis) the complete NOTCH1 receptor [66].
Given that the NOTCH4d1 protein includes most of the extracellular
domain, we were interested to determine if it could similarly inhibit
Notch signalling when expressed in cis. We performed Notch signal
transduction assays in which cells expressing DLL4 were cocultured
with NIH3T3 cells expressing various combinations of Notch4,Notch4d1
or Notch1 cDNAs and a synthetic Notch responsive luciferase reporter.
As expected, NOTCH1 robustly activated the luciferase reporter when
cocultured with DLL4 cells (Fig. 3A; lane 8). Unsurprisingly, NOTCH4d1,
which lacks the ICD required for signalling, did not activate the Notch
reporter above control (Fig. 3A; lane 7). However, NOTCH4 also
failed to elicit a signal upon coculture with DLL4 cells (Fig. 3A; lane
6). We conﬁrmed that NOTCH4 could not signal in endothelial cells
(Fig. S3A) or in non-endothelial cells in response to JAG1 expressing
cells (Fig. S3B). Even artiﬁcial activation of signalling by EDTA [69]
failed to elicit a detectable signal from NOTCH4 (Fig. S3C).
We were unable to induce NOTCH4 signalling in cultured cells.
This inability to signal may reside in the intracellular domain or ex-
tracellular domain. NotchΔE constructs span the membrane but
lack the LNR, HD and EGF-like repeats. Such truncated receptors
are constitutively active in the absence of ligand and thus constitute
a means to test the ability of a Notch receptor to be S3-cleaved and
subsequently activate Notch target gene transcription [27]. We
compared the signalling capacity of NOTCH4ΔE to NOTCH1ΔE by
transfecting these constructs into NIH3T3 cells. NOTCH4ΔE induced
the Notch reporter 480-fold over the vector control compared with
over 5000-fold activation by NOTCH1ΔE (Fig. 3B), consistent with
previous reports using ICD constructs [32,35,36]. Thus, once re-
leased, NOTCH4ICD does transduce a signal albeit at a lower levelthan NOTCH1ΔE, suggesting that NOTCH4ICD is not released at detect-
able levels from NOTCH4 in response to ligand. To investigate this fur-
ther, chimaeric receptor constructs, in which the intracellular domains
C-terminal to the S3-cleavage site were swapped (referred to as
NOTCH1:4 and NOTCH4:1; Fig. 3C), were tested in Notch signalling
assays. Ligand cells activated NOTCH1:4 by 5-fold, signiﬁcantly
lower than NOTCH1:1 (Fig. 3C). Nevertheless when placed in the
context of a functional receptor NOTCH4ICD can transduce a signal.
By contrast, NOTCH4:1 only activated the Notch reporter 2-fold in
response to ligand, despite the presence of the strong transactivation
domain of NOTCH1ICD (Fig. 3C). These data indicate that in response
to ligand, the NOTCH4 extracellular domain fails to release detect-
able levels of NOTCH4ICD.
Not only did NOTCH4 lack signalling capacity but also expression
of Notch4 with Notch1 inhibited NOTCH1-dependent signal trans-
duction (Fig. 3A; lane 9) and did so in a dose-dependent manner
(Fig. S3D). This inhibition was not due to competition for promoter
binding between theNOTCH1ICD andNOTCH4ICD because transfection
of increasing amounts of NOTCH4ΔE did not reduce ligand-induced
NOTCH1 signalling and instead increased signal output in a synergistic
manner (Fig. 3D). Consistent with this, NOTCH4d1, which lacks the in-
tracellular domain also inhibited activation of NOTCH1 by DLL4 ex-
pressing cells (Fig. 3A; lane 10). Thus, NOTCH4 could not transduce a
signal itself but inhibited signalling via NOTCH1 and this effect was
not mediated by the NOTCH4ICD. Importantly, the truncated form of
NOTCH4 overexpressed by the Notch4d1 allele retains this novel inhibi-
tory function.
Our Notch signal transduction assays demonstrated that NOTCH4
and NOTCH4d1 inhibited NOTCH1 signalling. To determine if this inhi-
bition induces a biological response, we examined C2C12 myoblast dif-
ferentiation into myocytes and myotubes as this is prevented by Notch
Fig. 3. NOTCH4 inhibits NOTCH1 signalling in cultured cells. (A) Notch signal transduction assay following coculture of ligand expressing (DLL4) or control cells, with NIH3T3 cells
transfected with various Notch receptor cDNAs (Notch4, Notch4d1, Notch1) and a Notch responsive luciferase reporter. (B) Notch signal transduction assay in NIH3T3 cells transfected
with increasing amounts (25, 50, 100, 200 ng per well) of either NOTCH1ΔE or NOTCH4ΔE and a Notch responsive luciferase reporter. (C) Signalling via chimaeric Notch receptors
coculturedwith JAG1 expressing cells. NIH3T3 cells were transfectedwith Notch chimaeric constructs and a Notch responsive reporter and signalling upon JAG1 coculturewas normalised
to coculturewith control cells. Diagram indicates chimaeric Notch receptor constructs containing sequences derived fromNOTCH1 (black) and NOTCH4 (white). EGF— epidermal growth
factor-like domain, LNR— Lin-12/Notch repeat, TM— transmembrane domain, ANK— Ankyrin repeat, AscI— AscI restriction enzyme site. (D) Notch signal transduction assay following
coculture of ligand-expressing (DLL4) or control cells, with NIH3T3 cells transfectedwith NOTCH1 (25 ng), increasing amounts of NOTCH4ΔE (25, 50, 100, 200 ng) and a Notch responsive
luciferase reporter. (A, B, and D) The columns represent the average relative luciferase activity and standard error of the mean of three independent experiments. Data were tested for
statistical signiﬁcance as described in the experimental procedures (Section 2.9). *P b 0.05, **P b 0.01. (E) Comparison of C2C12myoblast differentiation in control cells and those express-
ing Notch4 or Notch4d1 cDNA. Differentiated muscle cells were identiﬁed by reactivity to the pan-sarcomeric myosin antibody MF20 (green). Nuclei are stained with TO-PRO 3 (red).
NotchΔE constructs include the PEST sequence and span the membrane but lack the LNR, HD and EGF repeats. Scale bar: 200 μm.
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NOTCH4 or NOTCH4d1. These cell lines were difﬁcult to maintain in
an undifferentiated state and precociously differentiated under subopti-
mal differentiation conditions compared to control cell lines (Fig. 3E).
This ﬁnding is consistent with NOTCH4 and NOTCH4d1 inhibiting
Notch signal transduction and demonstrates that this inhibitory activity
can alter biological processes such as myoblast differentiation.NOTCH4 might inhibit NOTCH1 through interaction. Interaction
between NOTCH4 and NOTCH1 could inhibit NOTCH1 signalling by
interfering with the processing of NOTCH1. Full-length NOTCH1 is
processed in the TGN by FURIN or a FURIN-like convertase to form
a heterodimer [23,24]. Only heterodimeric NOTCH1 is presented on
the cell surface and is competent to receive signal [23–25,71]. There-
fore, to determine if NOTCH4 interacts with NOTCH1, we transfected
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NOTCH4 and immunoprecipitatedwith anti-FLAG antibody. Full-length
NOTCH1 speciﬁcally coprecipitated with NOTCH4 (Fig. 4A, lane 7).
However, processed, heterodimeric NOTCH1 did not coprecipitate
with NOTCH4 even though it was present in lysates (Fig. 4A, lanes 2
and 3). NOTCH4d1 also interacted with full-length NOTCH1 (Fig. 4A,
lane 9). Taken together these data indicate that NOTCH4 interacts ex-
clusively with the unprocessed full-length form of NOTCH1. Since
NOTCH4d1 also interacted with full-length NOTCH1, this interaction
must not rely on regions of NOTCH4 that are absent in NOTCH4d1;
that is, regions C-terminal to LNR-B (Fig. S1B).
NOTCH4 interacts with the unprocessed, full-length form of
NOTCH1 suggesting that these proteins interact before reaching the
TGN because NOTCH1 is S1-processed in the TGN [23]. We per-
formed live-cell imaging experiments to observe the localisation of
NOTCH1 in the absence and presence of NOTCH4. A fusion between
NOTCH4 and the red ﬂuorescent protein mRuby was created and
cloned into a tetracycline inducible expression vector. NOTCH4-Ruby
was transfected into C2C12 cells that stably express a NOTCH1-GFP fu-
sion receptor and ﬂuorescence was imaged following induction with
the tetracycline analogue doxycycline. NOTCH1-GFP was localised to
the plasma membrane and in cytoplasmic vesicles that were concen-
trated close to the nucleus in uninduced cells, a pattern that is indistin-
guishable from untagged NOTCH1 (Fig. 4B, 0 min) [58]. Once induced,Fig. 4. NOTCH4 interacts with NOTCH1 and alters its subcellular localisation. (A) Co-immun
transfected FLAG-tagged (FL) NOTCH4 or NOTCH4d1. Proteins were immunoprecipitated with
8) and immunoblotted to detect NOTCH1HA with anti-HA. Full-length (unprocessed: white ar
while heterodimeric NOTCH1 (black arrow) does not. IP (immunoprecipitation). WB (western
NOTCH1-GFP (green) and induced to expressNOTCH4-Ruby (red). Time (minutes) post inductio
of NOTCH4-Ruby expression (asterisk). Colocalisation of NOTCH1-GFP and NOTCH4-Ruby is in
increases the amount of full-length NOTCH1. NIH3T3 cells stably expressing myc-tagged NOT
800 ng) and immunoblotted to detect NOTCH1 (anti-myc), NOTCH4 (anti-HA) and β-actin (
NOTCH1). (D) Levels of full-lengthNOTCH1 (white bars) andNOTCH1 heterodimer (black bars)
relative to levels of NOTCH1 in the absence of NOTCH4HA.NOTCH4-Ruby was localised in a cytoplasmic network characteristic
of the endoplasmic reticulum (ER) but also in large cytoplasmic struc-
tures (Fig. 4B, 150 and 300 min). Upon induction of NOTCH4-Ruby,
the subcellular localisation of NOTCH1-GFP changed to match that of
NOTCH4-Ruby (Fig. 4B; Movie 1). Taken together these data suggest
that NOTCH4binds unprocessed, full-lengthNOTCH1 and in doing so al-
ters the subcellular localisation of NOTCH1. This suggests that NOTCH1
would not be efﬁciently S1-processed in cells expressing NOTCH4. To
investigate this, we transfected increasing amounts of Notch4 into a
NIH3T3 cell line stably expressing myc-tagged NOTCH1 and examined
S1-processing of NOTCH1 by western blot (Fig. 4C). As the amount of
transfected Notch4 increased, we observed increasing levels of unpro-
cessed full-length NOTCH1 (Fig. 4D). The ratio of full-length to hetero-
dimeric NOTCH1 also increased with increasing amounts of Notch4
transfected (Fig. 4D). The levels of heterodimeric NOTCH1 stayed con-
stant, most likely due to the protein's inherent stability [24]. These
data indicate that NOTCH4 interacts with full-length NOTCH1, alters
its trafﬁcking and perturbs its S1-processing.
3.4. Generation of mice with a deﬁnitive Notch4 null allele
Mice homozygous for the Notch4d1 allele (Notch4d1/d1) are viable
and fertile [11]. We have found that a truncated NOTCH4 protein is
expressed from the Notch4d1 allele, at levels greater than thoseoprecipitation of stably transfected HA-tagged NOTCH1 in C2C12 cells with transiently
either mouse anti-FLAG (FL, lanes 5, 7 and 9) or non-speciﬁc mouse IgG (Ig, lanes 6 and
row) NOTCH1 precipitates with NOTCH4 (lane 7) and NOTCH4d1 (lane 9) using anti-HA
blot). L (lysate). (B) Still images from live-cell imaging (see movie 1) of cells expressing
n of NOTCH4-Ruby is indicatedon the right. Cell expressingNOTCH1-GFPbefore induction
dicated by the arrow head. Scale bar: 20 μm. (C) Coexpression of NOTCH4 with NOTCH1
CH1 were transfected with increasing quantities of HA-tagged NOTCH4 (100, 200, 400,
anti-ACTB). White arrow (full-length NOTCH1). Black arrow (processed, heterodimeric
in (C) in the presence of increasing quantities of HA-tagged NOTCH4. Values are expressed
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inhibits Notch signalling (Fig. 3A). Therefore, the role of Notch4 in
vivo warrants further study.
To determine the phenotype of mice lacking Notch4 we generated
mice from embryonic stem (ES) cells targeted to replace the entire
Notch4 coding sequence with LacZ and neo expression cassettes
(Fig. 5A). This null allele Notch4tm1(KOMP)Vlcg will be referred to as
Notch4−. Mice homozygous for this Notch4 null allele (Notch4−/−)
were born at expected Mendelian ratios and were viable and fertile
(not shown).We conﬁrmed that theNotch4 locus was targeted correct-
ly by performing genomic PCR with primers amplifying exon 22 of
Notch4 (Fig. 5B; ex22), and ﬂanking the 5′ and 3′ recombination sites
(Fig. 5B; 5′/LacZ and neo/3′). These PCR products were sequenced to
conﬁrm the insertion site of the targeting cassette (data not shown).
NOTCH4 is not produced from the null allele as reactivity to anti-
NOTCH4 EC antibody could not be detected in Notch4−/− tissue
(Fig. S2B). Like the Notch4 transcript (Fig. 1B), β-galactosidase activity
driven from the Notch4 promoter was detected in the vasculature of
the head and in intersomitic vessels as well as the tail bud and
presomitic mesoderm of Notch4−/− E10.5 embryos but not Notch4+/+
embryos (Fig. 5C–F).
AlthoughNotch4−/−micewere viable, it is possible that the vascula-
ture might differ from that of Notch4+/+ mice. We therefore examined
postnatal retinal angiogenesis in the mouse as it proceeds in a deﬁned
spatio-temporal manner and is quantiﬁable [72,73]. The vasculature at
P5, as highlighted by anti-PECAM1 reactivity, had grown about three
quarters of the way to the edge of the retina and was undergoing re-
modelling as the initial plexus forms a mature vascular bed. At this
stage smooth muscle cell investment, as detected by ACTA2 expression
(Fig. 6A, B), was restricted to the arteries. We compared the effects of
the two Notch4 alleles (Notch4−, Notch4d1) on angiogenesis by staining
retinas from P5 mice with antibodies to PECAM1 and ACTA2. ACTA2
staining was not overtly different between genotypes (Fig. 6A, B). The
extent of vascular growth was assessed by measuring both total vessel
length within each retina as well as the area covered by the vascular
plexus. Notch4+/d1 and Notch4d1/d1 retinas showed a reduction in the
area covered by vasculature (18.0%; P = 0.003 and 17.4%; P = 0.022,
respectively) and a reduction in total vessel length (16.9%; P = 0.006
and 18.7%; P = 0.018, respectively) compared with Notch4+/+ litter-
mates (Fig. 6A, C, D). Notch4+/− and Notch4−/− retinas exhibited aFig. 5. Structure and conﬁrmation of theNotch4tm1(KOMP)Vlcg (Notch4−) allele. (A) Diagram of th
Notch4 gene. Lines indicate the positions of PCR products. (B) PCR of genomic DNA from Notch4
are 313 bp (ex22); 532 bp (5′/LacZ); and 544 bp (neo/3′). (C–F)Wholemountβ-galactosidase s
and 836 μm (E and F).reduction in vascular area (10.9%; P = 0.011 and 13.0%; P = 0.030,
respectively) compared with Notch4+/+ littermates (Fig. 6B, F).
Notch4+/− and Notch4−/− retinas also exhibited reduced vessel length
(9.7% and 9.8%) compared toNotch4+/+ littermates (Fig. 6B, G). Howev-
er, this difference only reached statistical signiﬁcance in the Notch4+/−
and not theNotch4−/− retinas (P= 0.0153 vs. 0.0636). These data indi-
cate that growth of the vasculature is delayed in mice carrying either of
the Notch4 alleles, although mice carrying the Notch4d1 allele are more
delayed than Notch4−/−mice. Vessel length density, the ratio of vessel
length to vascular area independent of vessel thickness (Fig. 6E, H),
and fractal dimension, a measure of the tortuosity of the vasculature
(not shown), were similar between all Notch4+, Notch4d1 and Notch4−
genotypes.
4. Discussion
NOTCH4 is almost exclusively expressed in vascular endothelial
cells, unlike NOTCH1, which is expressed in most tissues. Despite this,
NOTCH4 is the least studied of the mammalian Notch receptors and ac-
cordingly the least understood in terms of its signalling potential and
function. In cultured cells NOTCH4 has been reported to signal in re-
sponse to ligand by some but not all laboratories [38,39,74]. The
Notch4 knockout allele indicates in mice that Notch4 has a minor role
in embryonic angiogenesis (only on aNotch1 null background) and con-
tributes to initial tumour perfusion [11,44]. Therefore, we further inves-
tigated NOTCH4 signal transduction and its role during angiogenesis,
and made some surprising ﬁndings.
Firstly, we discovered that the reported Notch4 knockout allele
(Notch4d1) produced a transcript encoding virtually all the NOTCH4 ex-
tracellular domain. This transcript has the same vascular expression
pattern as the wildtype Notch4 allele in the mouse embryo and is
expressed at a 2-fold greater level than wildtype. For the ﬁrst time we
also document the expression pattern of the NOTCH4 protein in the de-
veloping retinal vasculature (Fig. 2). NOTCH4was predominantly found
at the growing vascular front with lower expression in established cap-
illary beds. At the growing vascular front, NOTCH4 was present in both
stalk and tip cells. Although overexpressed, the distribution of the
NOTCH4d1 protein was similar to NOTCH4 (Fig. 2).
We next demonstrated that NOTCH4 was unable to be activated by
ligand using a coculture assay where cell-bound ligand is presented toe Notch4 allele and the LacZ/neo cassette inserted between the start and stop codons of the
+/+,Notch4+/− and Notch4−/−mice amplifying regions indicated in (A). The PCR products
taining ofNotch4+/+ (C) andNotch4d1/d1 E10.5 embryos (D–F). Scale bar: 500 μm(C and D)
Fig. 6. The Notch4d1 and Notch4− alleles affect formation of the retinal vasculature. (A, B) Wholemount immunoﬂuorescence staining for the endothelial marker PECAM1 (red)
and smoothmusclemarker ACTA2 (green) of the retina of P5Notch4+/+,Notch4+/d1 andNotch4d1/d1 littermates (A) andNotch4+/+,Notch4+/− andNotch4−/− littermates (B). (C, F)Mea-
surements of the retinal vascular area inNotch4+/+,Notch4+/d1 andNotch4d1/d1 (C) andNotch4+/+,Notch4+/− andNotch4−/−mice (F). (D, G) Total vessel length ofNotch4+/+,Notch4+/d1
and Notch4d1/d1 (D) and Notch4+/+, Notch4+/− and Notch4−/− retinas (G). (E, H) Graphs of vessel length density inNotch4+/+, Notch4+/d1 and Notch4d1/d1 (E) and Notch4+/+, Notch4+/−
andNotch4−/− retinas (H). Measurements were normalised to themean of the heterozygotes in each litter. Red data points correspond to littermates of each genotype shown in A. and B.
These data were tested for statistical signiﬁcance as described in the experimental procedures (Section 2.9). *P b 0.05, **P b 0.01. Scale bar: 500 μm.
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by a CSL-binding transcriptional reporter assay (Fig. 3). NOTCH4 was
not activated in a variety of cell lines including an arterial endothelial
line (Fig. S3). Moreover, we were even unable to detect NOTCH4 signal
transduction after incubation with EDTA (Fig. S3), which is a powerful
activator of NOTCH1 due to its ability to chelate calcium ions and thus
unfold the negative regulatory region [69,75]. That we could not induce
NOTCH4 signal transduction is consistent with the ﬁndings of Aste-
Amezaga et al. [74] who could not detect ligand-induced signalling
from a Notch4–GAL4 activation domain fusion construct although sim-
ilar constructs based on Notch1–3 could signal [74]. Additionally, while
expression of the activated form of NOTCH4 (NOTCH4ICD) could induce
microvessels and expression of Jag1 and Notch4 itself, full-length
NOTCH4 had no effect [76]. However, in contrast to our ﬁndings and
that of others, NOTCH4 is reported to activate CSL-dependent reporter
transcription by 3.8-fold upon addition of DLL4 expressing cells [38]
and upregulate Notch target genes Flt4, Hey1 and Hey2 in response to
bothDLL4 and JAG1 [39]. It is not apparentwhy these reports are in con-
trast but they likely reﬂect differences in cell type, means and extent ofNOTCH4 overexpression, culture conditions and methods of detecting
signal transduction.
We obtained a good understanding of how the extracellular and
intracellular domains of NOTCH4 function by examining the activity
of constitutively active NOTCH4 and NOTCH1 and by generating
chimaeric Notch receptors. Firstly, we showed that a constitutively
active version of NOTCH4 (NOTCH4ΔE) is a poor activator of tran-
scription compared with NOTCH1ΔE (Fig. 3). This could be because
NOTCH4ΔE may not be efﬁciently γ-secretase cleaved compared to
NOTCH1ΔE. However, the intracellular domains of the Notch paralogues
also display a range of activation strengths on a variety of promoters in
vitro [32,35,36] and in vivo [77]. Both NOTCH1 and NOTCH2 contain se-
quences in the C-terminal region that act as a transcriptional activa-
tion domain (TAD). In the case of the NOTCH3, its intracellular
domain requires a nearby zinc ﬁnger binding site before it displays
transactivation activity [36]. No such requirement has been report-
ed for NOTCH4 and no TAD has been identiﬁed. NOTCH4, like
NOTCH3, may also require additional factors to efﬁciently activate
transcription.
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signal as strongly as a NOTCH1:4 chimaera. Chimaeric NOTCH4:1
contains all of the protease cleavage sites of NOTCH4 and therefore
measures the ability of NOTCH4 to respond to ligand, detected by
the strong transactivation activity of NOTCH1ICD. This chimaeric re-
ceptor generated low-level reporter activity indicating that, in the
context of the complete NOTCH4 receptor, ligand can induce minimal
receptor activation and ICD generation. In the NOTCH1:4 chimaera we
exploited NOTCH1's ability to signal in response to ligand to measure
the ligand induced signalling potential of NOTCH4ICD. In this chimaera
the addition of NOTCH4ICD to NOTCH1 produced a somewhat im-
proved transcriptional response compared with NOTCH4:1 or
NOTCH4:4. Observations from both chimaeras indicate that differ-
ences between the extracellular domains of NOTCH4 and NOTCH1
are the primary cause of the lack of NOTCH4 signal transduction. The
fact that constitutively active NOTCH4ΔE undergoes S3-cleavage [52]
implies that the NOTCH4 extracellular domain is defective upstream
of this event.
Further analysis of Notch signalling revealed that NOTCH4 inhibited
ligand-induced NOTCH1 signal transduction in cultured cells (Fig. 3).
Moreover, NOTCH4 inhibited the Notch-mediated inhibition of C2C12
myoblast differentiation (Fig. 3). This is the ﬁrst demonstration of a
complete Notch receptor inhibiting the signal transduction of another
Notch receptor, when expressed in the same cell. Notch signalling is
also inhibited when DSL ligands are expressed in the same cell as
the receptor, a phenomenon termed cis-inhibition. This cis-inhibition
by DSL ligands regulates Notch signal output separate from their ability
to induce signalling in trans, and is important for Notch-dependent lat-
eral inhibition and boundary formation in Drosophila, and perhaps ver-
tebrates as well [58,78]. Our ﬁndings indicate that cis-inhibition, not
only via DSL ligands but via other Notch receptors, also regulates
Notch signal transduction. The signiﬁcance of such receptor-mediated
cis-inhibition in vivo is currently not known. However, retention of
NOTCH4 cis-inhibitory activity in Notch4d1/d1 mice may explain the re-
duced extent of vasculature of Notch4d1/d1 retinas at P5 compared
with those of Notch4−/− mice. Further comparison of Notch4d1/d1 and
Notch4−/−mice should provide insight into the contribution of receptor
cis-inhibition to the overall function of NOTCH4 in vivo.
We established that the intracellular domain of NOTCH4
(NOTCH4ICD) did not inhibit NOTCH1 signalling (Fig. 3). This indi-
cates that the NOTCH4 extracellular domain mediated the inhibition.
This is consistent with our ﬁnding that NOTCH4d1 inhibited NOTCH1
signalling in ligand-induced signalling assays as well as in the myo-
blast differentiation assay (Fig. 3), as NOTCH4d1 consists only of
the extracellular part of NOTCH4. While investigating the mechanism
of inhibition,we demonstrated that NOTCH4 (aswell as NOTCH4d1) in-
teracts with full-length (unprocessed) NOTCH1 and that this interac-
tion leads to an accumulation of unprocessed NOTCH1 (Fig. 4); this
form of NOTCH1 cannot signal [25,71] and thus this interaction might
explain how NOTCH4 inhibits NOTCH1 signalling. There are reports of
Notch receptors forming dimers. For example, NOTCH1 and NOTCH2
can be co-immunoprecipitated with NOTCH1 [79–81]. As in our study,
the captured receptor is full-length and thus not S1 processed, and vir-
tually all of it is intracellular. Since FURIN cleavage of NOTCH1 occurs in
the TGN [23] and full-length NOTCH1 is largely localised to the ER [81],
dimerisation likely occurs early in the trafﬁcking pathway, prior to
reaching the TGN.
We postulated that the intracellular interaction of NOTCH4 and
NOTCH1 might cause the inhibition of NOTCH1 signalling by inter-
fering with the processing of NOTCH1 and its subsequent trafﬁcking.
If this were the case then NOTCH4 would be likely to disrupt the sub-
cellular localisation of NOTCH1. NOTCH1 is localised in intracellular
vesicles and to a lesser degree on the cell surface [58] and is con-
stantly internalised and recycled [82,83]. Using live-cell imaging
we show that NOTCH1 was mostly localised in intracellular puncta
and that induction of NOTCH4 in NOTCH1-expressing cells changedthe localisation of NOTCH1 to the same subcellular regions as
NOTCH4 in cells expressing both proteins (Fig. 4). The loss of
NOTCH1 positive vesicles available to participate in signalling could
therefore explain the inhibition of NOTCH1 signalling by NOTCH4.
The above ﬁndings lead us to propose a model of how NOTCH4
contributes to canonical Notch signal transduction. In terms of signal
transduction, NOTCH4 lacks detectable transactivating activity
compared with NOTCH1 because its extracellular domain fails to suf-
ﬁciently generate the ICD fragment. With respect to inhibition of sig-
nal transduction, NOTCH4 binds and sequesters full-length NOTCH1
preventing it from being S1-processed. It is interesting to note that
Notch4 expression is under the transcriptional control of canonical
Notch signalling. The Notch4 promoter contains CSL binding sites
[84] and Notch4 expression is upregulated by transfection with
Notch ICD constructs [40,76]. Thus NOTCH4 may serve to attenuate
NOTCH1 signalling in a negative feedback loop in a similar manner
to the Notch target Nrarp [33,85].
Approximately 50% of Notch4d1/d1; Notch1−/−mutants have a more
severe phenotype than Notch1−/− alone, suggesting NOTCH4 can
function redundantly with NOTCH1 during embryogenesis [11].
Affected embryos were found to have fewer somites, open neural
tubes and had not completed turning. In the vasculature the anterior
cardinal vein had collapsed [11]. This is seemingly at odds with our
ﬁnding that the primary function of NOTCH4 is as an inhibitor of
NOTCH1. However, it is also possible that NOTCH4 may signal as a
secondary role. We ﬁnd that while NOTCH4 could not signal in cell
culture, minimal signalling can be induced via the NOTCH4 EC if
fused with NOTCH1ICD. Therefore, there may be circumstances in
vivo that allow NOTCH4 to produce an effective signal and thus sup-
port NOTCH1's role during angiogenesis.
Finally we showed that NOTCH4 does not play a major role in em-
bryonic angiogenesis as we generated mice null for Notch4 and they
survived. We have however revealed a mild angiogenic phenotype in
the retinas of Notch4 null mice and those homozygous for the Notch4d1
allele. The extent of vessel coverage in Notch4− and Notch4d1 retinas at
P5 is reduced, suggesting that there is a delay in the growth of the vas-
cular plexus at this stage. This ﬁnding is consistent with the expression
of the NOTCH4 receptor that we report at the newly forming vascular
front. Inhibition of Notch signalling, via administration of γ-secretase
inhibitors, anti-Dll4 neutralising antibody, or reduced Dll4 dosage in-
creases the number of tip cells and results in a more dense network
[17–19]. Thus the removal of Notch4, which we report is an inhibitor
of NOTCH1, may be expected to reduce vascular density. Our ﬁnding
that the density of the vasculature is not signiﬁcantly altered by loss
ofNotch4 is at oddswith this. Although a direct quantitative comparison
of Notch receptor expression in vivo is not possible, we ﬁnd it much
harder to detect transcript and protein of Notch4 than Notch1 in the
embryo or postnatal retina. This indicates that expression of Notch4 is
much lower than that of Notch1 during development. This might ex-
plain why the mild angiogenic phenotype in the Notch4−/− retina is
not consistent with the loss of a NOTCH1 inhibitor. Thus loss of Notch4
may have more dramatic phenotypic consequences under conditions
that cause induction of NOTCH4 expression or in tissues that normally
express high levels of NOTCH4.
Although we have not revealed a major role for Notch4 in devel-
opmental angiogenesis, our ﬁndings are important as all knowledge
to date about this receptor in vivo is based on mouse lines that either
overexpress the constitutively active form of the receptor (which is
not physiological) or that carry an allele that is considered to be
null, but that rather overexpresses the extracellular domain of the
receptor [9,11,40,41,44,86]. Whether NOTCH4 functions in various
scenarios where angiogenesis occurs in the adult remains to be tested;
this can now be conﬁdently examined using the Notch4 null mice that
we have generated.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.03.015.
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